All News
View More
HIV Antiretroviral Reduced Alzheimer’s Risk Continuously, Study Shows

Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of Alzheimer’s disease by an average of 9% every year, according to new research published in Alzheimer’s and Dementia.

Endometriosis 101: A Disease Profile

An overview of endometriosis subtypes, treatment options and costs, according to a recent research review published in JAMA.

Time Well Spent: Lung Cancer Trials Offer Improved Survival Without Added Burden

Researchers are exploring the topic of "time toxicity" — how much time patients spend receiving care. This study is the first to directly compare time spent in care between clinical trial participants and routine care patients receiving the same treatments.

Depend on Biomakers, Not Symptoms, for Diagnosis, Early Treatment of GVHD, Experts Argue

John Levine, M.D., a graft-versus-host-disease expert at the Icahn School of Medicine at Mount Sinai in New York, makes a case for biomarkers in a review article published in the American Journal of Hematology.

FDA Sets Goal Date for Antipsychotic Drug, Bysanti

The FDA has accepted the new drug application for the antipsychotic Bysanti and set a goal date for February 21, 2026.

Proposed Medicaid Cuts Could Cost States Hundreds of Billions

The latest report by Urban Institute warns that proposed Medicaid funding cuts could cost states like California, New York, Massachusetts and the District of Columbia hundreds of billions of dollars over the next decade.

Changes at FDA, HHS Ranked No.1 Development, Survey Finds | MHE 2025 Pharmacy Survey, Part 1

The survey was conducted from March 10 through April 9, when the Department of Government Efficiency was in news

Waste in the Long Road to an IBD Cure

Finding a cure for inflammatory bowel disease (IBD) would mean reducing treatment waste, according to Ashwin N. Ananthakrishnan, M.D., M.P.H., MGH, associate professor of medicine at Massachusetts General Hospital and Johan Burisch, M.D., Ph.D., a gastroenterologist at Hvidovre Hospital in Denmark.

Healthcare Nirvana: Fewer Insurance Coverage Hassles

Nirvana, a healthcare technology startup, uses artificial intelligence to better predict insurance coverage.

Official Media Partners